SLC29A1 and familial pancreatic carcinoma: Marechal and colleagues recently investigated the predictive value of hENT1, dCK, and RRM1 in patients with pancreatic cancer treated with adjuvant gemcitabine chemotherapy and demonstrated that both hENT1 and dCK expressions were powerful predictive markers [17].